Could a common cholesterol drug help slow liver failure?
NCT ID NCT06764966
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether adding the statin atorvastatin to a standard beta blocker can help people with decompensated cirrhosis, a severe form of liver disease. Fifty participants will receive either atorvastatin plus their usual beta blocker or a placebo plus beta blocker, and be followed for 12 months. The goal is to see if the combination is safe, feasible, and may reduce complications like fluid buildup or bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Atorvastatin (a statin drug) plus a non-selective beta-blocker
What this could lead to
If successful, this could point toward a new combination therapy to slow liver disease worsening and reduce serious complications in cirrhosis patients.
What could go wrong
This is a small, early pilot study with only 50 participants, so results may not apply broadly. Statins have historically been avoided in liver disease due to safety concerns, though emerging evidence suggests they may be safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charleston Area Medical Center
RECRUITINGCharleston, West Virginia, 25304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact